FIELD: medicine.
SUBSTANCE: invention describes a method of cancer cell detection in pleural fluid or ascitic fluid in the patients suspected of malignant growths providing taking exudate from the examined patient in the amount of 10 ml; the serous fluid from the patient's pleural or abdominal cavity is placed in an artificial medium pressurised to make the entire examined exudate pass through a calibrated filter with a pore diameter of one thousand nanometres; the cancer cells are kept in a precipitation on the calibrated filter; the precipitation is applied on the slides pre-defatted and cooled to improve the cancer cell adherence and drying; then imprinted smears are fixed with 3% alcoholic Leishman solution for 2-4 minutes, further washed with distilled water and stained with an azure eosin mixture in ratio 3:1 for 15 minutes, washed with distilled water after staining, air-cured and observed under the microscope.
EFFECT: reduced time of analysis, higher accuracy of primary diagnosing in the patient, ease of implementation and availability.
2 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CANCER CELL DETECTION IN PERIPHERAL VENOUS BLOOD IN PATIENTS SUSPECTED OF MALIGNANT GROWTHS | 2009 |
|
RU2425385C1 |
METHOD FOR CONCENTRATING CELLULAR MATERIAL IN EXUDATES FOR CYTOLOGICAL EXAMINATION OF MALIGNANT NEOPLASMS | 2017 |
|
RU2663926C1 |
METHOD FOR PREDICTING THE RELAPSE OF SEROUS OVARIAN CANCER | 2005 |
|
RU2290078C1 |
METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH SEROUS RELAPSING OVARIAN CARCINOMA | 2005 |
|
RU2297788C1 |
METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH SEROSAL OVARIAN CANCER | 2005 |
|
RU2299018C1 |
METHOD FOR INTEGRATED MORPHOLOGICAL DIAGNOSTICS OF OVARIAN CANCER | 2015 |
|
RU2640189C2 |
PREDICTION METHOD OF LIFE DURATION IN PATIENTS WITH MESONEPHROID OVARIAN CARCINOMA | 2008 |
|
RU2357672C1 |
METHOD FOR PREDICTING SURVIVAL PERIOD IN SEROUS OVARY CARCINOMA PATIENTS OF REPRODUCTIVE AGE | 2005 |
|
RU2290640C1 |
METHOD FOR STABILIZING INDIVIDUAL SUBSTRATE FOR SPECTRAL MALIGNANCE DETERMINATION | 2002 |
|
RU2285443C2 |
LIFE SPAN PREDICTION METHOD FOR PATIENTS SUFFERING FROM MUCINOUS OVARIAN CARCINOMA | 2008 |
|
RU2354303C1 |
Authors
Dates
2013-10-10—Published
2012-01-12—Filed